Informações:
Falhas:
ID
44509
Descrição
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01540461
Link
https://clinicaltrials.gov/show/NCT01540461
Palavras-chave
Versões (2)
- 19/02/2020 19/02/2020 -
- 27/09/2021 27/09/2021 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
27 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatocellular Carcinoma NCT01540461
Eligibility Hepatocellular Carcinoma NCT01540461
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01540461
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Study Subject Inclusion criteria
Item
subjects with:
boolean
C0681850 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
Primary Malignant Liver Neoplasm Advanced | Liver carcinoma Advanced
Item
confirmed advanced primary liver cancer (hepatocellular carcinoma: hcc)
boolean
C0024620 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C2239176 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0205179 (UMLS CUI [1,2])
C2239176 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
Absence Systemic therapy Liver carcinoma Advanced
Item
not having received prior systemic treatment for advanced hcc
boolean
C0332197 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,4])
C1515119 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,4])
Liver function Child-Pugh Classification | Liver Dysfunction Moderate Child-Pugh Classification | Child-Pugh - Total Score
Item
normal or moderately impaired liver function (child-pugh class a or b (cp total score of ≤ 7))
boolean
C0232741 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
C0086565 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C4050412 (UMLS CUI [2,3])
C4055253 (UMLS CUI [3])
C4050412 (UMLS CUI [1,2])
C0086565 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C4050412 (UMLS CUI [2,3])
C4055253 (UMLS CUI [3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Study Subject Exclusion Criteria
Item
subjects with:
boolean
C0681850 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain | Leptomeningeal disease
Item
brain metastasis or evidence of leptomeningeal disease
boolean
C0220650 (UMLS CUI [1])
C0751297 (UMLS CUI [2])
C0751297 (UMLS CUI [2])
Brain function Impaired | Encephalopathy | Heart Disease
Item
history of impaired brain function (encephalopathy) or active heart disease
boolean
C0678908 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0085584 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
C0221099 (UMLS CUI [1,2])
C0085584 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
Fluid-filled abdomen | Ascites
Item
unmanageable fluid in the abdomen (ascites)
boolean
C0685931 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0003962 (UMLS CUI [2])
Bleeding esophageal varices | Bleeding gastric varices
Item
bleeding esophageal or gastric varices within 2 months prior to inclusion
boolean
C0155789 (UMLS CUI [1])
C0267209 (UMLS CUI [2])
C0267209 (UMLS CUI [2])